| Literature DB >> 33552440 |
Salahuddin Nasir1, Moustafa Abou Areda2, Elise L Ma2, Robert D Chow2, Avelino Verceles3, Carol Chiung-Hui Peng2.
Abstract
A 21-year-old male presented with a 2-week history of nausea and non-bloody, non-bilious vomiting, accompanied by diffuse chronic myalgia. The patient endorsed headaches, dizziness, and diplopia that had started one day prior to admission. The patient had consumed a meat-only diet for the prior year. The patient was found to have a high anion gap metabolic acidosis with a superimposed normal anion gap metabolic acidosis in the setting of a several-month history of ingesting multiple naturopathic substances as well as recent use of disulfiram for management of his chronic myalgia. Magnetic resonance imaging (MRI) of the brain demonstrated symmetric hyperintensity involving bilateral thalami, periventricular regions, putamina, pons and medulla, with sparing of the mammillary bodies, consistent with Wernicke's encephalopathy (WE). The patient was treated with intravenous thiamine, a balanced nutritional diet, and hydration. Over the ensuing four days, his metabolic derangements resolved and a repeat MRI demonstrated significantly decreased FLAIR signal abnormality.Entities:
Keywords: Diet; High-protein; Thiamine; Wernicke encephalopathy; Wernicke’s syndrome
Year: 2021 PMID: 33552440 PMCID: PMC7850391 DOI: 10.1080/20009666.2020.1843236
Source DB: PubMed Journal: J Community Hosp Intern Med Perspect ISSN: 2000-9666
Initial laboratory tests
| pH (venous) | 7.26 |
| pCO2 (venous) | 24 mmHg |
| Anion Gap | 28 |
| Bicarbonate | 8 mEq/L |
| Chloride | 110 mEq/L |
| Lactate | 1.6 mmol/L |
| Serum Total Protein | 10.5 g/dL |
| Albumin | 5.1 g/dL |
| WBC count | 2800/mcL |
| Hemoglobin | 18.5 g/dL |
| Hematocrit | 51.9% |
| Platelets | 117/mcL |
| Serum CK | 44 U/L |
| TSH | 4.43 mU/L |
| T4 | 0.96 ug/dL |
Figure 1.Comparison of signal intensity in brain magnetic resonance imaging before and after treatment with intravenous thiamine. Arrows on Figure 1A and 1B, pointed to the thalami and on Figure 1C and 1D, the arrows pointed to the midbrain. After treatment with intravenous thiamine, Figure 1B and 1D showed a significant reduction in signal intensity in magnetic resonance imaging in these regions, compared to Figure 1A and 1C, respectively